Hypertrophic cardiomyopathy is a leading cause of sudden death in young athletes, requiring careful family screening, exercise restriction, and medical or surgical management.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to screen athletes for HCM; leaves open optimal restriction and intervention trials.
In brief: Hypertrophic cardiomyopathy is the most common cause of sudden death in young conditioned athletes. The disorder is largely genetic, so families of patients need careful screening. Patients are often asymptomatic, but symptoms can include chest pain, near-syncope, palpitations, and dyspnea. A prominent S4 gallop and a systolic murmur that is accentuated with standing and during Valsalva's maneuver suggest the diagnosis. Certain ECG, echocardiography, and cardiac catheterization features can help confirm the diagnosis. Athletes with hypertrophic cardiomyopathy should be restricted from vigorous exercise and treated with large doses of beta blockers. Antiarrhythmic agents are added, if necessary. Surgery is considered when large ventricular gradients are present and when symptoms do not respond to drug therapy.
No takes yet. Share an insight, caveat, or question.
John D. Cantwell (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: